Nuplazid / pimavanserin trials

Nuplazid / pimavanserin is approved for Parkinson’s psychosis. It is only sold through specialty pharmacies at a very high price. It is not used off label.
There are, however, two phase 3 clinical trials for adjunctive use for schizophrenia. One of the trials is for negatives. So in 2025 or so, the med use Might change.